Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid function and plasma cyclic AMP response to intravenous glucagon.

S N Madsen

    Acta Endocrinologica
    |August 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Mars Environmental Dynamics Analyzer, MEDA. A Suite of Environmental Sensors for the Mars 2020 Mission.

    Space science reviews·2021
    Same author

    Accuracy of digital tympanic, oral, axillary, and rectal thermometers compared with standard rectal mercury thermometers.

    The European journal of surgery = Acta chirurgica·2000
    Same author

    [Ventricular tonometry during laparoscopic cholecystectomy].

    Ugeskrift for laeger·1997
    Same author

    [Incisional hernia. A study of morbidity, mortality and bed utilization in a Danish county].

    Ugeskrift for laeger·1996
    Same author

    The clinical effect of naproxen sodium after arthroscopy of the knee: a randomized, double-blind, prospective study.

    Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·1993
    Same author

    [Recurrent toxic shock syndrome in a man after surgery for a pilonidal cyst].

    Ugeskrift for laeger·1982

    Thyroid status affects cyclic AMP response to glucagon. While treatment can normalize this response, some patients exhibit persistent changes, suggesting hormonal inertia.

    Area of Science:

    • Endocrinology
    • Molecular Biology
    • Metabolism

    Background:

    • Thyroid hormones significantly influence cellular metabolism and signaling pathways.
    • Cyclic adenosine monophosphate (cAMP) is a crucial second messenger involved in various cellular responses, including those stimulated by glucagon.

    Purpose of the Study:

    • To investigate the impact of hyperthyroidism and hypothyroidism on the glucagon-stimulated increase in plasma cyclic AMP.
    • To assess the diagnostic utility of the plasma cyclic AMP response to glucagon for evaluating thyroid states.
    • To examine the reversibility of altered cyclic AMP responses following treatment for thyroid dysfunction.

    Main Methods:

    • Studied plasma cyclic AMP levels in response to intravenous glucagon administration in healthy subjects, hyperthyroid patients, and hypothyroid patients.

    Related Experiment Videos

  • Re-evaluated a subset of treated hyperthyroid and hypothyroid patients after a minimum of 15 months of treatment.
  • Main Results:

    • Hyperthyroid patients exhibited an increased cyclic AMP response to glucagon, while hypothyroid patients showed a reduced response.
    • A significant number of hyperthyroid and hypothyroid patients displayed normal responses, indicating the test's limited sensitivity for peripheral thyroid states.
    • Treatment normalized cyclic AMP responses in most patients, but a persistent hyper-response to glucagon was observed in some treated hyperthyroid patients, suggesting hormonal inertia.

    Conclusions:

    • The glucagon-stimulated cyclic AMP response is altered in thyroid dysfunction but is not a consistently sensitive indicator of peripheral thyroid states.
    • Thyroid hormone effects on liver cAMP may not directly correlate with effects on other tissues.
    • Hormonal inertia may explain persistent alterations in glucagon sensitivity after normalization of thyroid hormone levels.